|
MTFMT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.51760999999029E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.33250000000385E-05 |
| Normal-vs-Stage2 |
7.620300E-02 |
| Normal-vs-Stage3 |
4.22140000000404E-05 |
| Normal-vs-Stage4 |
3.67479999999754E-05 |
| Stage1-vs-Stage2 |
2.428600E-01 |
| Stage1-vs-Stage3 |
4.005200E-01 |
| Stage1-vs-Stage4 |
1.328160E-01 |
| Stage2-vs-Stage3 |
1.260370E-01 |
| Stage2-vs-Stage4 |
4.981600E-02 |
| Stage3-vs-Stage4 |
4.575400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63226999999599E-05 |
| Normal-vs-AfricanAmerican |
3.357800E-01 |
| Normal-vs-Asian |
6.403600E-04 |
| Caucasian-vs-AfricanAmerican |
9.160500E-02 |
| Caucasian-vs-Asian |
9.368200E-01 |
| AfricanAmerican-vs-Asian |
1.143760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.60809999999456E-05 |
| Normal-vs-Female |
4.05100000000491E-05 |
| Male-vs-Female |
2.870200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.57929999999552E-05 |
| Normal-vs-Age(41-60Yrs) |
6.45889999999483E-05 |
| Normal-vs-Age(61-80Yrs) |
2.624200E-04 |
| Normal-vs-Age(81-100Yrs) |
1.551970E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.045400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.522200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.568200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.400400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.109400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.915000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.142800E-03 |
| Classical-VS-Follicular |
3.088200E-01 |
| Classical-VS-Other |
3.791900E-02 |
| Classical-VS-Normal |
2.302600E-03 |
| Tall-VS-Follicular |
6.083800E-02 |
| Tall-VS-Other |
6.380800E-01 |
| Tall-VS-Normal |
6.52879999951672E-07 |
| Follicular-VS-Other |
1.598640E-01 |
| Follicular-VS-Normal |
7.606600E-04 |
| Other-VS-Normal |
8.778600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.213700E-04 |
| Normal-vs-N1 |
1.06040000114049E-08 |
| N0-vs-N1 |
9.605100E-04 |
|
|
